Resalis Therapeutics
0 followers
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, in... Read more
Org chart
Alessandro Toniolo
Collapse
Riccardo Panella
Chief Scientific Officer & Co-founder
Claus Andersson
Non-executive Director
Barbara Domizzi
Project Coordinator And Budget Planner
Almut Nitsche
Chief Medical And Development Officer
Sakari Kauppinen
Chief Technology Officer & Co-founder
Antonio Leone
Non-executive Director
Michael Hodges
Board Member
Pietro Puglisi
Board Member
Luca Borgio
Head Of Operations
